Next-gen weight-loss drugs will be here within 12 months
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Amy Schumer Reveals She Is Using Weight Loss Drugs Again Despite Past 'Horrible Experience'
Amy Schumer has revealed that she's back on a new weight loss drug after her "horrible experience" with Wegovy.
Amy Schumer having 'good experience' with new weight loss drug after suffering severe Ozempic side effects
Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult time using Ozempic years ago.
Amy Schumer on switching weight-loss medications
The comedian shares why she changed medications after what she described as a bad experience years ago. Diners, Drive-Ins and Dives premiered on the Food Network in 2007. As dives and greasy spoons started making a comeback with hipsters and foodies,
Amy Schumer 'Has More Energy' After Using Weight-Loss Drug
Amy Schumer has had a “really good experience” with a new weight-loss drug. The 43-year-old star previously confessed to having a difficult time with Wegovy, the popular weight-loss drug, but Amy has recently adopted a new drug called Mounjaro and she’s been much happier with the results.
Amy Schumer Announces Decision On Weight Loss Drug
Comedian Amy Schumer has opened up about her decision on weight loss drugs. Schumer, 43, has been open about her battles with losing weight as a woman in Hollywood. The longtime comedian and "Trainwreck" star previously took a weight loss drug,
FDA approves new drug to treat protein buildup in the heart
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
STAT3d
Alnylam enters the ATTR-CM drug race
Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.
Health and Me on MSN5h
FDA Approves Tremfya For Active Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called ...
The FDA can save lives by keeping copycat drugs off the market
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Moore: FDA can save lives by nixing copycat drugs
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Mounjaro, the injection to fight type-2 diabetes, draws global attention as new weight loss drug
Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
JD Supra14h
FDA Update: Current Guidelines for Semaglutide and Tirzepatide Compounding
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...